No Data
2 Covered Call Ideas on Pfizer Stock
CFRA Initiates Pfizer(PFE.US) With Hold Rating, Announces Target Price $31
Pfizer's Former CEO Pitches Board on Starboard's Shake up Plan, FT Reports
Express News | Pfizer, BioNTech Win Bid in UK Court to Invalidate CureVac's Patents Over Mrna Technology in Covid-19 Vaccines
Why Pfizer Will Find It Hard to Appease Its Activist Investor -- WSJ
TD Cowen Maintains Pfizer(PFE.US) With Hold Rating, Maintains Target Price $32